![]() |
|
|
Vol. 17, Issue 11, 4632-4644, November 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




,||

*Department of Biochemistry and #McGill Cancer Center, McGill University, Montreal, Quebec, Canada H3G 1Y6;
Department of Biophysics and Biophysical Chemistry, John Hopkins University School of Medicine, Baltimore, MD 21205-2185;
Lady Davis Institute for Medical Research, McGill University, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Quebec, Canada H3T 1E2;
Howard Hughes Medical Institute and ||Departments of Biological Chemistry and Internal Medicine, University of Michigan, Ann Arbor, MI 48109; and ¶Department of Biochemistry, School of Medicine, Case Western Reserve University, Cleveland, OH 44106-4935
Submitted June 1, 2006;
Revised August 4, 2006;
Accepted August 14, 2006
Monitoring Editor: Sandra Schmid
A cornerstone of the antiviral interferon response is phosphorylation of eukaryotic initiation factor (eIF)2
. This limits the availability of eIF2·GTP·Met-tRNAiMet ternary complexes, reduces formation of 43S preinitiation complexes, and blocks viral (and most cellular) mRNA translation. However, many viruses have developed counterstrategies that circumvent this cellular response. Herein, we characterize a novel class of translation initiation inhibitors that block ternary complex formation and prevent the assembly of 43S preinitiation complexes. We find that translation driven by the HCV IRES is refractory to inhibition by these compounds at concentrations that effectively block cap-dependent translation in vitro and in vivo. Analysis of initiation complexes formed on the HCV IRES in the presence of inhibitor indicates that eIF2
and Met-tRNAiMet are present, defining a tactic used by HCV to evade part of the antiviral interferon response.
This article was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E06-06-0478) on August 23, 2006.
Address correspondence to: Jerry Pelletier (jerry.pelletier{at}mcgill.ca)
This article has been cited by other articles:
![]() |
S. Mokas, J. R. Mills, C. Garreau, M.-J. Fournier, F. Robert, P. Arya, R. J. Kaufman, J. Pelletier, and R. Mazroui Uncoupling Stress Granule Assembly and Translation Initiation Inhibition Mol. Biol. Cell, June 1, 2009; 20(11): 2673 - 2683. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bechill, Z. Chen, J. W. Brewer, and S. C. Baker Coronavirus Infection Modulates the Unfolded Protein Response and Mediates Sustained Translational Repression J. Virol., May 1, 2008; 82(9): 4492 - 4501. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Raven, D. Baltzis, S. Wang, Z. Mounir, A. I. Papadakis, H. Q. Gao, and A. E. Koromilas PKR and PKR-like Endoplasmic Reticulum Kinase Induce the Proteasome-dependent Degradation of Cyclin D1 via a Mechanism Requiring Eukaryotic Initiation Factor 2{alpha} Phosphorylation J. Biol. Chem., February 8, 2008; 283(6): 3097 - 3108. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Baltzis, O. Pluquet, A. I. Papadakis, S. Kazemi, L.-K. Qu, and A. E. Koromilas The eIF2{alpha} Kinases PERK and PKR Activate Glycogen Synthase Kinase 3 to Promote the Proteasomal Degradation of p53 J. Biol. Chem., October 26, 2007; 282(43): 31675 - 31687. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kazemi, Z. Mounir, D. Baltzis, J. F. Raven, S. Wang, J.-L. Krishnamoorthy, O. Pluquet, J. Pelletier, and A. E. Koromilas A Novel Function of eIF2{alpha} Kinases as Inducers of the Phosphoinositide-3 Kinase Signaling Pathway Mol. Biol. Cell, September 1, 2007; 18(9): 3635 - 3644. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pelletier Exploring Translation Initiation as a Chemotherapeutic Target Am. Assoc. Cancer Res. Educ. Book, April 14, 2007; 2007(1): 147 - 152. [Full Text] [PDF] |
||||